biolife4d corp on monday said it was raising the size of its planned initial public offering to 36 million units from 24 million the units are still expected to price between 520 and 720 each as previously disclosed the company said the biotech company said it plans to create a patientspecific fully functioning heart through 3d bioprinting using the patients own cells the company said it has applied to list on the nasdaq capital market aegis capital corp is listed as the offerings underwriter